TRANSGENIC MICE EXPRESSING HIGH-LEVELS OF HUMAN APOLIPOPROTEIN-B DEVELOP SEVERE ATHEROSCLEROTIC LESIONS IN RESPONSE TO A HIGH-FAT DIET

被引:166
作者
PURCELLHUYNH, DA
FARESE, RV
JOHNSON, DF
FLYNN, LM
PIEROTTI, V
NEWLAND, DL
LINTON, MF
SANAN, DA
YOUNG, SG
机构
[1] GLADSTONE INST CARDIOVASC DIS,SAN FRANCISCO,CA 94141
[2] UNIV CALIF SAN FRANCISCO,CARDIOVASC RES INST,SAN FRANCISCO,CA 94143
[3] UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94143
关键词
TRANSGENIC MICE; ATHEROSCLEROSIS; APOLIPOPROTEIN B; CHOLESTEROL; LOW DENSITY LIPOPROTEINS;
D O I
10.1172/JCI117915
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
We previously generated transgenic mice expressing human apolipoprotein (apo-) B and demonstrated that the plasma of chow-fed transgenic animals contained markedly increased amounts of LDL (Linton, M. F., R, V, Farese, Jr., G. Chiesa, D. S. Grass, P. Chin, R. E. Hammer, H. H. Hobbs, and S. G. Young 1992. J. Clin. Invest. 92:3029-3037). In this study, we fed groups of transgenic and nontransgenic mice either a chow diet or a diet high in fat (16%) and cholesterol (1.25%). Lipid and lipoprotein levels were assessed, and after 18 wk of diet, the extent of aortic atherosclerotic lesions in each group of animals was quantified, Compared with the female transgenic mice on the chow diet, female transgenic mice on the high-fat diet had higher plasma levels of cholesterol (312+/-17 vs 144+/-7 mg/dl; P < 0.0001) and human apo-B (120+/-8 vs 84+/-3 mg/dl; P < 0.0001), The higher human apo-B levels were due to increased plasma levels of human apo-B48; the human apo-B100 levels did not differ in animals on the two diets, In mice on the high-fat diet, most of the human apo-B48 and apo-B100 was found in LDL-sized particles. Compared with nontransgenic mice on the high-fat diet, the transgenic animals on the high-fat diet had significantly increased levels of total cholesterol (312+/-17 vs 230+/-19 mg/dl; P < 0.0001) and non-HDL cholesterol (283+/-17 vs 193+/-19 mg/dl; P < 0.0001). The extent of atherosclerotic lesion development within the ascending aorta was quantified by measuring total lesion area in 60 progressive sections, using computer-assisted image analysis. Neither the chow-fed transgenic mice nor the chow-fed nontransgenic mice had significant atherosclerotic lesions. Nontransgenic animals on the high-fat diet had relatively small atherosclerotic lesions (< 15,000 mu m(2)/section), almost all of which were confined to the proximal 400 mu m of the aorta near the aortic valve. In contrast, transgenic animals on the high-fat diet had extensive atherosclerotic lesions (> 160,000 mu m(2)/section) that were widely distributed throughout the proximal 1,200 mu m of the aorta. Thus, human apo-B expression, in the setting of a diet rich in fats, causes severe atherosclerosis in mice.
引用
收藏
页码:2246 / 2257
页数:12
相关论文
共 40 条
[1]  
BOSTROM K, 1990, J BIOL CHEM, V265, P22446
[2]   A RECEPTOR-MEDIATED PATHWAY FOR CHOLESTEROL HOMEOSTASIS [J].
BROWN, MS ;
GOLDSTEIN, JL .
SCIENCE, 1986, 232 (4746) :34-47
[3]   HEPATIC ACAT ACTIVITY IN AFRICAN-GREEN MONKEYS IS HIGHLY CORRELATED TO PLASMA LDL CHOLESTERYL ESTER ENRICHMENT AND CORONARY-ARTERY ATHEROSCLEROSIS [J].
CARR, TP ;
PARKS, JS ;
RUDEL, LL .
ARTERIOSCLEROSIS AND THROMBOSIS, 1992, 12 (11) :1274-1283
[4]   LIPOPROTEIN PROFILE CHARACTERIZATION OF THE KKA(Y) MOUSE, A RODENT MODEL OF TYPE-II DIABETES, BEFORE AND AFTER TREATMENT WITH THE INSULIN-SENSITIZING AGENT PIOGLITAZONE [J].
CASTLE, CK ;
COLCA, JR ;
MELCHIOR, GW .
ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (02) :302-309
[5]  
CHIESA GL, 1993, J BIOL CHEM, V268, P23747
[7]  
GRASS DS, 1994, CIRCULATION, V90, pA134
[8]  
INNERARITY TL, 1990, J LIPID RES, V31, P1337
[9]   HYPERCHOLESTEROLEMIA IN LOW-DENSITY-LIPOPROTEIN RECEPTOR KNOCKOUT MICE AND ITS REVERSAL BY ADENOVIRUS-MEDIATED GENE DELIVERY [J].
ISHIBASHI, S ;
BROWN, MS ;
GOLDSTEIN, JL ;
GERARD, RD ;
HAMMER, RE ;
HERZ, J .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (02) :883-893
[10]   MASSIVE XANTHOMATOSIS AND ATHEROSCLEROSIS IN CHOLESTEROL-FED LOW-DENSITY-LIPOPROTEIN RECEPTOR-NEGATIVE MICE [J].
ISHIBASHI, S ;
GOLDSTEIN, JL ;
BROWN, MS ;
HERZ, J ;
BURNS, DK .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (05) :1885-1893